Compared to natural plasmalogens that already have an anti-neuroinflammation effect our synthetic derivitative of plasmalogen has the following improvements:
KIT-13, a synthetic derivative of plasmalogen, has been shown strong anti-inflammatory effects by inhibiting the nuclear accumulation of p65, suppressing the expression of IL-1β, and inducing phosphorylation of ERK.
These findings suggest that KIT-13 may hold promise for treating RTT and other conditions where plasmalogen levels are diminished and caused neuroinflammation.
NeuroCores's synthetic plasmalogens have been developed from decades of research by the world's leading plasmalogen research group.
These plasmalogen derivatives have more substantial anti-neuroinflammatory effects than natural plasmalogen, indicating excellent therapeutic potential for a wide range of neurological disorders and neurodegenerative diseases.
KIT-13 significantly reduces neuroinflammation in Rett Syndrome model mice
Copyright © 2024 Neurocores - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.